Back to
UBS Group AG
CYTK29 quarters
Position history for
UBS Group AG's holdings in CYTOKINETICS INC
UBS Group AG holds 2.1M shares of CYTK (CYTOKINETICS INC), worth $136.9M as of 2026-Q1. The position was increased (+83.6% shares). CYTK represents 0.0% of UBS Group AG's portfolio.
Current Value
$136.9M
Current Shares
2.1M
Total Value Change
+$136.9M
Total Shares Change
+2.1M
Quarter-by-Quarter History
Other major holders of CYTK: BlackRock Finance, Inc., BlackRock, Inc.